Tamara van Donge

Ibuprofen-related maturational adverse events in ELBW neonates 161 8 References 1. Abitbol CL, DeFreitas MJ, Strauss J. Assessment of kidney function in preterm infants: lifelong implications. Pediatric Nephrology. 2016;31(12):2213-2222. 2. Faa G, Gerosa C, Fanni D, et al. Marked interindividual variability in renal maturation of preterm infants: lessons from autopsy. The Journal of Maternal-Fetal & Neonatal Medicine. 2010;23(sup3):129-133. 3. Hoogenboom LA, Wolfs TG, Hütten MC, Peutz-Kootstra CJ, Schreuder MF. Prematurity, perinatal inflammatory stress, and the predisposition to develop chronic kidney disease beyond oligonephropathy. Pediatric Nephrology. 2020:1-9. 4. Vieux R, Hascoet J-M, Merdariu D, Fresson J, Guillemin F. Glomerular filtration rate reference values in very preterm infants. Pediatrics. 2010;125(5):e1186-e1192. 5. George I, Mekahli D, Rayyan M, Levtchenko E, Allegaert K. Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates. Pediatric nephrology. 2011;26(10):1843- 1849. 6. van den Anker J, Reed MD, Allegaert K, Kearns GL. Developmental Changes in Pharmacokinetics and Pharmacodynamics. The Journal of Clinical Pharmacology. 2018;58(S10):S10-S25. 7. Allegaert K, Smits A, Van Donge T, et al. Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions. Frontiers in Pediatrics. 2020;8. 8. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. A Simple Estimate of Glomerular Filtration Rate in Children Derived From Body Length and Plasma Creatinine. Pediatrics. 1976;58(2):259-263. 9. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. Journal of the American Society of Nephrology. 2009;20(3):629-637. 10. van Donge T, Allegaert K, Gotta V, et al. Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life. Pediatric Nephrology. 2020. 11. Allegaert K, Van De Velde M, van den Anker J. Neonatal clinical pharmacology. Pediatric Anesthesia. 2014;24(1):30-38. 12. Allegaert K, Verbesselt R, Naulaers G, et al. Developmental pharmacology: neonates are not just small adults…. Acta Clinica Belgica. 2008;63(1):16-24. 13. Mitra S, Florez ID, Tamayo ME, et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Jama. 2018;319(12):1221-1238. 14. Fanos V, Antonucci R, Zaffanello M. Ibuprofen and acute kidney injury in the newborn. The Turkish journal of pediatrics. 2010;52(3):231. 15. Antonucci R, Fanos V. NSAIDs, prostaglandins and the neonatal kidney. The Journal of Maternal- Fetal & Neonatal Medicine. 2009;22(sup3):23-26. 16. Fanos V, Benini D, Verlato G, Errico G, Cuzzolin L. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus. Fundamental & clinical pharmacology. 2005;19(2):187-193. 17. Allegaert K, Cossey V, Langhendries J, et al. Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life. Neonatology. 2004;86(3):207-211.